Inventor · disambiguated record
Avedis Karadeolian
Also filed as: KARADEOLIAN AVEDIS
9 granted patents·8 pending applications·7 citations·filing 2015–2023
78Inventor score
Files withAPOTEX INC17
Top patents by PatentIndex Score
17 records- 0181US9260438B2Solid forms of tofacitinib saltsAPOTEX INC·Filed 2015·Granted Feb 16, 2016·3 cites·4 claims
- 0280US11236066B2Crystalline forms of niraparib tosylateAPOTEX INC·Filed 2020·Granted Feb 1, 2022·1 cites·20 claims
- 0379US10513504B2Processes for the preparation of apalutamide and intermediates thereofAPOTEX INC·Filed 2019·Granted Dec 24, 2019·2 cites·19 claims
- 0478US11046638B2Processes for the preparation of zuclomiphene and intermediates thereofAPOTEX INC·Filed 2020·Granted Jun 29, 2021·1 cites·17 claims
- 0570US11814356B1Salt of cabozantinibAPOTEX INC·Filed 2023·Granted Nov 14, 2023·0 cites·16 claims
- 0664US2024116884A1Salts of ViloxazineAPOTEX INC·Filed 2023·Application pending·0 cites
- 0763US2024018090A1Processes for the Preparation of FenfluramineAPOTEX INC·Filed 2023·Application pending·0 cites
- 0860US11667656B2Crystalline forms of Tenofovir alafenamideAPOTEX INC·Filed 2021·Granted Jun 6, 2023·0 cites·20 claims
- 0960US11578025B2Processes for the preparation of zuclomiphene intermediatesAPOTEX INC·Filed 2021·Granted Feb 14, 2023·0 cites·16 claims
- 1060US2025049774A1Crystalline Forms of ApalutamideAPOTEX INC·Filed 2022·Application pending·0 cites
- 1159US2025019346A1Salts of Ruxolitinib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 1255US2023093124A1Salts of Nintedanib and Crystalline Forms ThereofAPOTEX INC·Filed 2022·Application pending·0 cites
- 1351US2023279036A1Salts of RemdesivirAPOTEX INC·Filed 2021·Application pending·0 cites
- 1450US2021292272A1Salts of ZuclomipheneAPOTEX INC·Filed 2021·Application pending·0 cites
- 1548US10351537B2Processes for the preparation of lesinurad and intermediates thereofAPOTEX INC·Filed 2018·Granted Jul 16, 2019·0 cites·20 claims
- 1645US10301322B2Processes for the preparation of edoxaban and intermediates thereofAPOTEX INC·Filed 2017·Granted May 28, 2019·0 cites·3 claims
- 1743US2019330150A1Processes for the Preparation of 3-(4-Halobutyl)-5-CyanoindoleAPOTEX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Avedis Karadeolian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →